Waters, NIBRT Partner to Grow Knowledge of Large-Molecule Characterization - - BioPharm International

ADVERTISEMENT

Waters, NIBRT Partner to Grow Knowledge of Large-Molecule Characterization


BioPharm Bulletin
Volume 25, Issue 4

The National Institute for Bioprocessing Research and Training (NIBRT) in Ireland and Waters are partnering on training and research to increase large-molecule characterization capacity and knowledge, according to an NIBRT press release.

The two organizations established the Complete Product and Processing Characterization Facility for hands-on laboratory-based scientific training and retraining of “fit-for-purpose” biopharmaceutical analysis, including protein and peptide characterization. The goal of the facility is to provide comprehensive training of industry and governmental technicians and scientists in an effort to develop advanced biotherapeutic characterization Training on US and European drug regulations will also be offered. Finally, the partnership establishes NIBRT as a Waters Center of Innovation in the area of glycobiology research.

“Ireland is a leading location globally for the development and manufacture of complex biopharmaceutical drugs. This is due in large part to a sustained commitment to quality and compliance with the highest regulatory standards,” said NIBRT’s Interim Director Prof. Ian Marison.

“Through this lab and other collaborations, Waters will work with industry to improve the development of biopharmaceuticals and inform governments on the types of regulations that should be put in place,” said Mike Harrington, Waters vice-president, European Operations.

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Merck KGaA Announces Acquisition of Sigma-Aldrich for $17 Billion
September 22, 2014
Pandemic Vaccine Facility Dedicated in Texas
September 19, 2014
GSK Fined in China Bribery Scandal
September 19, 2014
Guideline Delineates How to Implement GS1 Standards to Support DSCSA
September 19, 2014
GPhA Supports Restricted Access Bill
September 18, 2014
Author Guidelines
Source: BioPharm Bulletin,
Click here